Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62d1b8b0c95dc64dbe7e020d6c97f74f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22 |
filingDate |
2007-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d273264e66585e57ef0718359fe7ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0634dcffe2020c779b0ae181d668b8e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecd3020db96e6ad551b1a203643c3ae9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28b59a198ed87813a246080099a4f9e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8270669add6bd9b525c3b1f9579ff33 |
publicationDate |
2008-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2008056669-A |
titleOfInvention |
Inhibitors based on fusion, HR1 and HR2 sequences in bacterial adhesins |
abstract |
Disclosed is an inhibitor on a non-immune basis for meningococcal infection. It binds to the heptad repeat sequence HR1 and / or HR2 of NadA adhesin on the surface of Neisseria meningitidis, thereby infecting the host organism or expanding an existing infection A compound that can inhibit any ability, wherein the HR1 sequence is residues 117-152 and the HR2 sequence is residues 261-299. Binding to the heptad repeat sequences HR1 and / or HR2 of HadA adhesins on the surface of Haemophilus bacteria, thereby inhibiting the ability of Haemophilus bacteria to infect host organisms or to spread existing infections A compound wherein the HR1 sequence is 71-91 and the HR2 sequence is residues 120-183. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8704848-B2 |
priorityDate |
2004-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |